Doxorubicin (DOX) is a natural antibiotic with antineoplastic activity. It has been used for
over 40 years and remains one of the most used drugs in chemotherapy for a variety of …

The second‐generation taxane cabazitaxel has been clinically approved for the treatment of
metastatic castration‐resistant prostate cancer after docetaxel failure. Compared with the …

The combination of chemotherapy and photodynamic therapy (PDT) has promising potential
in the synergistic treatment of cancer. However, chemotherapy and photodynamic …

Minimizing drug leakage in systemic circulation, synchronizing the in vivo fate of multiple
drugs, and precisely controlling tumor locoregional drug release, remain challenging for …

Cancer therapy with nanoscale drug formulations has made significant progress in the past
few decades. However, the selective accumulation and release of therapeutic agents in the …

Accurate tumor targeting, deep penetration and superb retention are still the main pursuit of
developing excellent nanomedicine. To achieve these requirements, a stepwise stimuli …

Antibody-drug conjugates (ADCs) are a class of tumor cell-targeting drugs that have
developed rapidly in recent years. From the perspective of further improving ADC targeting …

Chemotherapy is one of the most conventional modalities for cancer therapy. However, the
high multidrug resistance of tumor cells still limited the clinical application of current …

Chemo-photothermal treatment is one of the most efficient strategies for cancer therapy.
However, traditional drug carriers without near-infrared absorption capacity need to be …

We herein explored a smart Fe-HPPy@ Au/DOX theranostic agent for CT diagnosis and
PTT/chemotherapy/CDT synergistic treatment of cancer. When the Fe-HPPy@ Au/DOX …